MANAGEMENT OF MUSCULOSKELETAL EVENTS (MSES) IN A PHASE 2 STUDY (HALO 109-202) OF METASTATIC PANCREATIC CANCER PATIENTS RECEIVING A NOVEL TREATMENT APPROACH OF PEGPH20 (PEGVORHYALURONIDASE ALFA) PLUS NAB-PACLITAXEL/GEMCITABINE (PAG)-A NURSING PERSPECTIVE
ONCOLOGY NURSING FORUM（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined